Generic drugs in India is a real threat, says Katherine Eban


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
Indian Generic drugs are all sham .... says award winning journalist Katherine Eban

An explosive narrative investigation of the drug boom from an award-winning journalist Katherine Eban, reveals fraud and life-threatening dangers on a worldwide scale. Her novel, an NYT bestseller ‘Bottle of Lies’ accounts for how the world’s greatest public-health innovation has become one among its most astonishing scams.

Today, almost 90 percent of our pharmaceutical market is comprised of generics, the bulk of which are manufactured overseas. We've been reassured by our doctors, our pharmacists and our regulators that generic drugs are just like their brand-name counterparts, just less costly. But is that really true?

Eban published a gripping account after erstwhile Ranbaxy Laboratories admitted to selling adulterated drugs in an American court.

Katherine draws accounts from moles and watchdogs, along with thousands of pages of confidential FDA documents, and rips off an industry where fraud is rampant.

What’s heartening for consumers is the Central Drugs Standard Control Organisation (CDSCO), which never found problems with the company’s drugs in India. Katherine recurred the discrepancy between the FDA’s and CDSCO’s accounts in the book.

She mentioned, the CDSCO, never critically acted against the biggest offenders, such as Ranbaxy and Hyderabad’s GVK Biosciences. For GVK Biosciences, the European Medicines Agency (EMA) found the company to be manipulating drug-quality data in 2015. Former CDSCO chief G.N. Singh, however, tries to explain away the findings by referring it as conspiracies against the Indian industry.

These generic drugs have plagued the market so deep that patients consume these cheap-alternate medicines with unpredictably dangerous effects. The story of generic drugs is actually global. It connects middle America to China, India, Sub-Saharan Africa and Brazil, and represents the last word the litmus test of globalization: what are the risks of moving drug manufacturing offshore, and are they well worth the savings?

Tags : #katherineeban #fakegenerics #indiagenerics #medicircle

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026